Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Wegovy injection is a once-weekly subcutaneous (under-skin) injection of semaglutide, administered via a pre-filled pen into the abdomen, thigh, or upper arm. Clinical trials published in the New England Journal of Medicine showed an average body-weight reduction of around 15% over 68 weeks at the 2.4 mg maintenance dose, achieved by people following a consistent weekly injection routine alongside lifestyle changes. Getting the technique right from the first pen matters, and the full Wegovy overview explains the broader treatment context. These are prescription-only medicines: a prescriber assesses your suitability before any pen is dispensed, and your Patient Information Leaflet is the authoritative source for storage windows and clinical detail specific to your pen.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The prescribing information for Wegovy (held on the electronic Medicines Compendium (eMC)) sets out the technique that underpinned every clinical trial. Before you begin, take the pen from the fridge and leave it at room temperature for roughly 30 minutes; a cold pen can make the injection sting more than it needs to. Wash your hands thoroughly. Remove the pen cap and check the window: the liquid inside should be clear and colourless, or very slightly yellow. If it looks cloudy, has particles floating in it, or is a stronger colour than expected, do not use that pen and contact your prescriber or pharmacy.
That quick visual check takes under a minute, and it is the single habit most worth building into your routine.
Attach a new needle, peel off both caps, then clean the injection site with an alcohol swab and let the skin dry completely before injecting, injecting through wet skin is less comfortable and can sting. Pinch a fold of skin gently with your free hand, hold the pen at a 90-degree angle and press it flat against the skin. Push the button, keep the pen pressed in place until the injection counter shows zero, then hold for a further five to ten seconds. Release the skin fold, withdraw the pen and dispose of the used needle in a sealed sharps container.
Three anatomical areas are licensed for Wegovy: the abdomen, the front and outer thigh, and the outer upper arm. Each has practical advantages. The abdomen is easiest to access and easiest to see clearly. The thigh is a good option for people who self-inject alone at home. The upper arm is manageable for most people and is the site described in more detail on the guide to arm injections if that is your preference.
Rotation matters more than most people realise. Injecting into the same small spot repeatedly can cause a localised build-up of fat tissue (lipohypertrophy), which reduces how reliably the medicine is absorbed. A practical system is to mentally divide each site into a grid and move one square along each week. Keep the abdomen injections at least five centimetres from the navel, and avoid any area of skin that is sore, bruised, scarred or has any sign of a skin condition.
If you are taking an oral contraceptive pill, the NHS England guidance on weight-management injections notes no current evidence that semaglutide reduces pill absorption, unlike the equivalent guidance for tirzepatide. Your prescriber will have covered contraception at consultation, but it is worth raising any questions at your next clinical review. For a broader look at how semaglutide compares with other weight-loss injections, that page sets out the differences clearly.
The most frequently reported side effects in the STEP 1 trial were gastrointestinal: nausea, diarrhoea, vomiting and constipation, occurring most often in the first weeks of treatment or after a dose increase. For most participants these were mild to moderate and settled as the body adjusted. Smaller, lower-fat meals tend to ease nausea; staying well hydrated matters particularly if diarrhoea occurs.
Injection-site reactions such as redness, itching or minor bruising do happen, typically shortly after the injection and resolving within a day or two. They are usually linked to technique or rotating too slowly between sites. A blunt or reused needle is a common culprit: a fresh needle every time significantly reduces local discomfort.
There are symptoms that warrant urgent medical attention rather than waiting to see if they settle: severe, persistent stomach pain, particularly pain that radiates towards the back, should be assessed promptly as this may indicate pancreatitis, which the MHRA identified as a known but infrequent risk in its January 2026 Drug Safety Update for GLP-1 medicines. Signs of an allergic reaction, including swelling, difficulty breathing or a widespread rash, also need immediate medical attention. For a fuller picture of what to expect and when to act, the semaglutide side-effects guide covers the full profile.
Life happens and an injection gets forgotten. The Patient Information Leaflet advises injecting the missed dose as soon as you remember, provided there are at least five days until your next scheduled injection. If fewer than five days remain, skip the missed dose and resume your normal day. Never inject two doses to make up for one skipped. Your prescriber is the right person to ask if this happens repeatedly or if you are unsure how to handle a specific situation, the how-to guide for Wegovy covers this and other practical questions in more detail.
If you are thinking about starting treatment or are partway through and have questions about your current plan, the team at nume reviews every consultation individually, and support is available seven days a week. You can also read about Wegovy treatment costs if pricing is a factor in your decision. When you are ready, speak to our prescribers through a free consultation, the same day, with a real clinician.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.